Early-onset pamidronate therapy may reduce disease activity in chronic nonbacterial osteomyelitis
Treatment with pamidronate appears to improve clinical and radiological disease activity in children categorized with extended chronic nonbacterial osteomyelitis (CNO), particularly after 1 year of treatment, a study has shown. However, some children present with active disease after 2 years of pamidronate use.